About IOPtima
IOPtima is a Healthcare company based in Caesarea (Israel) founded in 2005. It operates as an ophthalmic therapeutics, including laser applications and eye drops, are developed. IOPtima offers products and services including IOPtiMate®, iLid™, Lipitear™, and Fabilas™. Its focus areas include Life Sciences, Diabetes, Medical Devices and Therapeutic Devices. Its competitors include Bausch & Lomb, Lamellar, Dopavision, Katena and Appasamy Associates and 5 more; 5 of its 10 listed competitors have raised funding.
Company details
IOPtima was founded in 2005 in Caesarea, Israel, within the healthcare sector focused on ophthalmology. Therapeutics products for eye care are developed, encompassing laser technologies for glaucoma surgery, eyelid procedures, and internal eye pressure management, as well as microemulsion drops for dry eye treatment. Operations center on innovation in medical devices and pharmaceuticals tailored to ocular conditions.
- Headquarters Caesarea, Israel
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ioptima.com
- Social LinkedIn Instagram YouTube
Products & Services of IOPtima
IOPtima offers a comprehensive portfolio of products and services, including IOPtiMate®, iLid™, Lipitear™, and Fabilas™.
Laser system to reduce intraocular pressure for glaucoma treatment.
CO2 laser kit for eyelid surgery and skin resurfacing procedures.
Preservative-free formula for relieving dry eye symptoms effectively.
Multi-purpose system for ocular treatments with high precision and safety.
Apps and channels of IOPtima
its YouTube channel IOPtimaVideos has 95 subscribers and 30 videos.
Videos from IOPtima
The most watched videos on IOPtima's YouTube channel, IOPtimaVideos (95 subscribers). Click a video to play it here.
More on IOPtimaVideos.
Competitors of IOPtima
IOPtima has 10 listed competitors in our database, 5 of them funded. They include Bausch & Lomb, Lamellar, Dopavision, Katena and Appasamy Associates, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bausch.com | 1853 | Bridgewater, United States | – | 1,681 | Ophthalmic pharmaceuticals and instruments are developed for eye care. | |
| lamellar.com | 2007 | Bellshill, United Kingdom | $18.39M | 5 | Develops patented medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies | |
| dopavision.com | 2017 | Berlin, Germany | $15.54M | – | Digital therapeutics for myopia are developed via retinal light stimulation. | |
| katena.com | 1975 | Tampa, United States | $7.5M | 145 | Ophthalmic surgical instrument manufacturer | |
| appasamy.com | 1978 | Chennai, India | – | 4,259 | Ophthalmic instruments and pharmaceutical products are developed for eye care. | |
| acufocus.com | 2001 | Irvine, United States | $219.07M | 27 | Developer of small aperture technology-based ophthalmic devices | |
| beaver-visitec.com | 2010 | Waltham, United States | – | – | Microsurgical products for ophthalmology and specialties are manufactured and marketed. | |
| dorcglobal.com | 1983 | Zuidland, Netherlands | – | – | Ophthalmic research center | |
| katalystsurgical.com | 2010 | St. Louis, United States | $340,000 | 53 | Titanium ophthalmic surgical instruments are manufactured and repaired. | |
| moria-surgical.com | 1820 | Antony, France | – | – | Precision instruments for eye surgery are designed and manufactured. |
Detailed competitors of IOPtima
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Diabetes
10 companies that operate in the same segment as IOPtima (Diabetes), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 | |
Implantable continuous glucose monitoring systems are provided for diabetes management. | 1996 | Germantown, United States | USD 175.46 M | USD 22.47 M | 117 | |
Developer of a closed-loop automated insulin delivery system | 2014 | Milpitas, California, United States | USD 214.51 M | – | 133 | |
Provider of workforce healthcare solutions | 2015 | New York, New York, United States | USD 107.87 M | – | 166 | |
Diabetes care and reversal programs are provided to patients. | 2021 | Bengaluru, Karnataka, India | USD 26.7 M | USD 5.07 M | 677 | |
Provider of smart devices for diabetes management for patients and doctors | 2014 | San Francisco, California, United States | USD 237 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 253 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ioptima
Complete news archive for IOPtima
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IOPtima
IOPtima was founded in 2005.
IOPtima is headquartered in Caesarea, Israel. It is registered at Caesarea, Haifa, Israel.
IOPtima was founded in 2005 in Caesarea, Israel, within the healthcare sector focused on ophthalmology. Therapeutics products for eye care are developed, encompassing laser technologies for glaucoma surgery, eyelid procedures, and internal eye pressure management, as well as microemulsion drops for dry eye treatment. Operations center on innovation in medical devices and pharmaceuticals tailored to ocular conditions.
IOPtima's top competitors include Bausch & Lomb, Appasamy Associates and Katalyst Surgical.
IOPtima offers IOPtiMate®, iLid™, Lipitear™, and Fabilas™.